am thrilled to sign the African Medicine Agency @AUAMA -@WHO Framework Agreement for Collaboration alongside my sister, Delese Mimi Darko. Together, we will work to enhance access to quality medicines throughout Africa, reinforcing our commitment to #HealthForAll. Continental institutions play a vital and complementary role alongside global organizations, and WHO will continue to provide both financial and technical support.
The African Medicines Agency can be one of the most powerful driving forces for African Health Sovereignty - H.E. Mustpha Ferjani, Minister of Health, Tunisia
We’re proud to announce that the African Medicines Agency (AMA) has signed an MoU with @USPharmacopeia (USP)! This partnership will strengthen regulatory systems, advance harmonization, and expand access to safe, effective, and quality-assured medicines across Africa.
The AMA is also pleased to join the USP Convention, contributing to global standards and collaboration to strengthen trust in medical products. This strategic partnership is building stronger, more coordinated health systems for the continent.
Read more at https://t.co/z73Jxn4pWH
#AMA #HealthSecurity #GlobalHealthPartnerships
Today in Johannesburg, the Director General of the African Medicines Agency (AMA), Dr Delese Mimi Darko, delivered the keynote address at the opening of the USP Africa Regional Chapter Meeting.
Speaking under the theme “Partnering for Progress: Localisation and Building Regulatory Capacity for Next-Gen Medicines in Africa,” she underscored a critical point: Africa has regulatory and technical capacity, but this is not yet fully connected.
AMA’s mandate is to connect this existing capacity, foster effective collaboration among National Regulatory Authorities (NRAs), and serve as an enabler for coordinated, continent-wide regulatory strengthening.
Dr Darko highlighted the tremendous progress Africa has made in medicines regulation and reaffirmed AMA’s commitment to ensuring this progress is sustained, harmonised, and future-ready, in close partnership with NRAs and institutions such as USP.
Strong partnerships will be key to delivering safe, quality, next-generation medicines for Africa.
Today, following a joint guidance from the Director-General of AMA, Dr Delese Mimi Darko and the Director-General of Africa CDC, Dr Jean Kaseya core technical staff of AMA and Africa CDC met to align on three priority areas namely:
1. Develop a continental quality assurance policy to guide procurement under the African Pooled Procurement Mechanism
2. Agree on procedures for prioritization of medical products for continental listing.
3. Coordinate support to local manufacturers on the continent through the complementary activities of the AMA SME & Innovation Office and the Africa CDC Business Acumen Facility.
Both institutions are pleased to be working together to advance health sovereignty through a robust, harmonized, and resilient health infrastructure, driving stronger systems, greater coordination, and improved health outcomes across the continent.
#QualityAssurance #AHSS #AfricanManufacturing
#AMA
#AfricaCDC
On Wednesday, 8 April 2026, H.E. Dr Delese Mimi Darko, Director General of the African Medicines Agency (AMA), paid a courtesy visit to Dr Fiona Braka, Country Representative to @WHOGhana .
The meeting focused on progress in AMA’s operationalisation and explored opportunities for collaboration to enhance regulatory capacity and performance in Ghana and across Africa.
Why Stronger Medical Products Regulation Is Essential to Drive Africa’s Health Investments
At #UNECA58, AMA DG H.E. Dr. Delese Mimi Darko highlighted a key message:
“Health financing delivers impact only when regulatory systems are coordinated and trusted”
Fragmented pathways slow approvals and delay access. AMA’s continental approach streamlines reviews, strengthens reliance, and ensures Africa’s investments translate into timely, safe, quality-assured medical products.
Stronger regulation = smarter investment + better access for patients across Africa.
#MedicalProductsRegulation #AMA #AfricaHealth #HealthFinancing #Tangier
H.E. Dr Delese Mimi Darko, Director-General of the African Medicines Agency (AMA), delivered a keynote address at the West Africa Biomanufacturing Regulation & Market Access Forum, calling for stronger regulatory coordination to support Africa’s growing biomanufacturing sector and ensure access to safe, quality and efficacious medicines on the continent.
“Africa’s biomanufacturing future will be defined not by ambition alone, but by whether we build systems that work: systems that regulators trust, industry can navigate, and patients can rely on."
New Dean Appointment!
Today, we celebrate the appointment of Professor Cornelius Cecil Nii Dodoo as Dean of School of Pharmacy - UHAS, whose term starts on August 1, 2026. He takes over from Professor Kwame Ohene Buabeng, whose tenure ends on July 31, 2026.
From 25–26 February 2026, leaders from government, academia, industry, and development partners convened in Kigali for the inaugural Regional Capability and Capacity Network (RCCN) – East Africa Conference of Partners Workshop.
The Africa CDC initiative aims to strengthen workforce capabilities and expand local vaccine and health product manufacturing across the region.
The AMA is calling on 24 AU member states to ratify its treaty “without delay.”
Delays leave gaps in protection against substandard & falsified medicines & weaken Africa’s regulatory sovereignty.
✍️@kerrycullinan11@AU_AMA_@AfricanUnion @DrDarkoAMA
https://t.co/7ziOyY43nm
Today, H.E. Dr Delese Mimi Darko (AMA) met H.E. Dr Jean Kaseya (Africa CDC) in Addis Ababa to reaffirm joint action, clarify complementary mandates, and boost cooperation in areas like pooled procurement and AfCFTA-linked health trade.
#Africa#AMA#AfricaCDC#HealthSecurity
AMA takes part in the High‑Level Meeting on Equitable Access & Local Manufacturing of Health Products in Africa. In her remarks, DG Dr. Delese Mimi Darko stressed that strong, predictable & harmonised regulation is essential for Africa’s manufacturing goals
#AMA
On the sidelines of the AU Summit, the AMA hosts a High-Level Presidential Breakfast on the Operationalisation and Universal Ratification of the African Medicines Agency (AMA) for quality medical products and health security in Africa.
Very constructive meeting with the Executive Secretary of #UNECA today.
The African Medicines Agency (AMA) is not just about regulation.
It is about trust.
It is about markets.
It is about industrial development.
It is about Africa’s health sovereignty.
Big shifts underway.
#AMA #AfricaHealth @ECA_OFFICIAL@_AfricanUnion@claverGatete@amma_twumamoah@mimi_darko@HIV_CWG
Congratulations to Director-General, H.E. Dr Delese Mimi Darko, a #TIME100Health 2026 Titan! Her leadership amplifies Africa’s voice and excellence in global health.
https://t.co/g5L1jYlV1f
AMA was honoured to host Anvisa, Fiocruz and Butantan during their Trade & Investment Mission to Kigali. We explored opportunities for regulatory collaboration, with AMA and Anvisa set to begin work on key shared priorities to strengthen access to quality medical products.
A dynamic day 2 of the Maiden Heads of National Regulatory Agencies & Regional Economic Community Coordinators' Forum is underway in Kigali, Rwanda.